Soybean oil, hydrogenated
CAS 8016-70-4
Soybean oil, hydrogenated (CAS 8016-70-4) is a pharmaceutical compound with 0 bioactivity targets and 1 adverse event association.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Soybean oil, hydrogenated is linked through DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Soybean oil, hydrogenated used for in pharmaceutical contexts?
Soybean oil, hydrogenated (CAS 8016-70-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Soybean oil, hydrogenated?
Soybean oil, hydrogenated has 1 DrugCentral/FAERS adverse event association. Rendered reaction terms include Hyponatraemia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Soybean oil, hydrogenated also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hydrogenated Soybean Oil with EU status "permitted".
What clinical phase is Soybean oil, hydrogenated in?
No phase 1-4 clinical development badge is rendered for Soybean oil, hydrogenated because the matched compound identifier rows do not contain a max-phase value.